secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001628280-23-020697
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland Pharmaceuticals appoints Carr, Riggs & Ingram as new independent auditor for FY 2023
--------------------------------------------------------------------------------

- Appointed CRI as independent registered public accounting firm for FY ending Dec 31, 2023, effective for interim period ending June 30, 2023.
- No prior consultations with CRI on accounting principles or audit opinion type.
- No disagreements or reportable events between the company and predecessor auditor as defined in Regulation S-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828023020697/0001628280-23-020697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828023020697/cpix-20230530.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-020697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer